Look for:

Our offer for

GILEAD SCIENCES INC.


ISIN:
US3755581036
WKN:
375558103

2020/07/07 22:00:00
Price
76.42 USD
Difference -0.44% (-0.34)

General attributes

ISINUS3755581036
SymbolGILD
ExchangeNasdaq
CurrencyUSD
SectorChemical / Pharmaceutical / Health
Security typeStock
Market cap (m)85,814 EUR
BenchmarkS&P 500

Market data

Bid (Bid size)76.01 USD (200)
Ask (Ask size)76.85 USD (300)
Open76.49 USD
High76.96 USD
Low76.31 USD
Close (prev. day)76.76 USD
VWAP76.63 USD
Volume (pcs)5,055,744
Trading volume387,210,372.01
Number of trades47,269
Last size553,073

Futures and Options

Related Futures15
Related Options-

PDF Downloads

Company report: GILEAD SCIENCES INC.PDF Download

Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Recent research



2020/07/07 22:00:00
Price
76.42 USD
Difference -0.44% (-0.34)

General attributes

ISINUS3755581036
SymbolGILD
ExchangeNasdaq
CurrencyUSD
SectorChemical / Pharmaceutical / Health
Security typeStock
Market cap (m)85,814 EUR
BenchmarkS&P 500

Market data

Bid (Bid size)76.01 USD (200)
Ask (Ask size)76.85 USD (300)
Open76.49 USD
High76.96 USD
Low76.31 USD
Close (prev. day)76.76 USD
VWAP76.63 USD
Volume (pcs)5,055,744
Trading volume387,210,372.01
Number of trades47,269
Last size553,073

Performance and Risk

6m1Y3Y
Perf (%)+17.35%+11.51%+10.35%
Perf (abs.)+11.30+7.89+7.17
Beta0.490.510.63
Volatility49.6637.7629.95
Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Price data

Ø price 5 days | Ø volume 5 days (pcs.)76.51 USD (7,136,565)
Ø price 30 days | Ø volume 30 days (pcs.)75.46 USD (10,583,424)
Ø price 100 days | Ø volume 100 days (pcs.)75.28 USD (19,616,092)
Ø price 250 days | Ø volume 250 days (pcs.)69.17 USD (12,341,057)
YTD High | date85.97 USD (2020/03/19)
YTD Low | date62.23 USD (2020/01/21)
52 Weeks High | date85.97 USD (2020/03/19)
52 Weeks Low | date60.89 USD (2019/10/03)

All listings for GILEAD SCIENCES INC.

Exchange  DateTimePriceTrading volume (mio.)Number of trades
Xetra2020/07/0810:1567.87 EUR0.0812
Vienna Stock Exchange2020/07/0809:0567.81 EUR0.001
Tradegate2020/07/0810:1668.09 EUR0.2049
Stuttgart2020/07/0810:0967.90 EUR0.038
SIX Swiss Exchange2020/05/1117:3572.00 CHF0.001
SIX Swiss Exchange2020/04/1717:3585.00 USD0.001
Nasdaq2020/07/0722:0076.42 USD387.2147,269
Munich2020/07/0808:0067.68 EUR0.001
London Stock Exchange European Trade Reporting2020/07/0809:0476.985 USD0.001
Hanover2020/07/0808:0667.34 EUR0.001
Hamburg2020/07/0808:0667.34 EUR0.001
Frankfurt2020/07/0809:2367.99 EUR0.032
Duesseldorf2020/07/0808:2167.60 EUR0.002
Borsa Italiana MTF Trading After Hours2020/07/0718:2468.09 EUR0.001
Borsa Italiana MTF Global Equity Market2020/07/0809:1567.61 EUR0.001
Berlin2020/07/0808:1267.90 EUR0.002

Company Logo

https://gateway.mdgms.com/extern/logo_image.html?ID_LOGO=1964&ID_TYPE_IMAGE_LOGO=2

Contact Details

GILEAD SCIENCES INC.
Sung Lee
Lakeside Drive 333 94404 Foster City, California
Telefon: +1-650-574-3000
Fax: +1-650-578-9264
E-mail: investor_relations@gilead.com

PDF Downloads

Company report: GILEAD SCIENCES INC.PDF Download

Company Profile

Gilead Sciences is a biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need. The company's mission is to advance the care of patients suffering from life-threatening diseases. Gilead has operations in more than 35 countries worldwide, with headquarters in Foster City, California.

Members of Management Board

Daniel O'DayChairman of Board of Directors
- Javier J. RodriguezMember of Board of Directors
Richard J. WhitleyMember of Board of Directors
Per Wold-OlsenMember of Board of Directors
Kevin E. LoftonMember of Board of Directors
Kelly A. KramerMember of Board of Directors
Harish ManwaniMember of Board of Directors
George P. ShultzMember of Board of Directors
Gayle Edlund WilsonMember of Board of Directors
Sandra J. HorningMember of Board of Directors
John F. CoganMember of Board of Directors
Jacqueline K. BartonMember of Board of Directors
Daniel O'DayChairman of Managing Board
Jyoti MehraMember of Executive Committee
Johanna MercierMember of Executive Committee
Christi L. ShawMember of Executive Committee
Brett PletcherMember of Executive Committee
Andrew DickinsonMember of Executive Committee
William A. LeeMember of Executive Committee
Taiyin YangMember of Executive Committee
Merdad ParseyMember of Executive Committee






Accept

We use cookies and web analysis software to give you the best possible experience on our website. By continuing to browse this website, you consent for these tools to be used. For more details and how to opt out of these, please read our Data protection policy.

INFORMATION FOR PRIVATE CLIENTS / CONSUMERS

Any information, material and services regarding financial instruments and securities provided by Česká spořitelna/Erste Group/ or any of its affiliates (collectively “Erste Group“) on this and any linked website hereafter (jointly the “Websites“) shall be exclusively to investors who are not subject to any legal sale or purchase restrictions.

By agreeing to this hereto, the visitor entering this Websites confirms that has read, understood and accepted this Information and the Disclaimer